Although dopamine D1 and D2 receptors belong to distinct subfamilies of dopamine receptors, several lines of evidence indicate that they are functionally linked. However, a mechanism for this linkage has not been elucidated. In this study, we demonstrate that agonist stimulation of co-expressed D1 and D2 receptors resulted in an increase of intracellular calcium levels via a signaling pathway not activated by either receptor alone or when only one of the coexpressed receptors was activated by a selective agonist. Calcium signaling by D1-D2 receptor co-activation was abolished following treatment with a phospholipase C inhibitor, but not with pertussis toxin, or inhibitors of protein kinase A or protein kinase C, indicating coupling to the Gq pathway. We also show, by co-immunoprecipitation from rat brain and from cells coexpressing the receptors, that D1 and D2 receptors are part of the same heteromeric protein complex and, by immunohistochemistry, that these receptors are co-expressed and co-localized within neurons of human and rat brain. This demonstration that D1 and D2 receptors have a novel cellular function when co-activated in the same cell represents a significant step towards elucidating the mechanism of the functional link observed between these two receptors in brain.
Introduction
The dopamine D1 receptor has been shown to signal via Gs and Golf proteins to stimulate adenylyl cyclase (1) and there have been reports of calcium signaling by D1 receptormediated phosphatidylinositol (PI) 1 hydrolysis by phospholipase C (PLC), presumably through Gq coupling. Although PLC activity was not detected in studies on the D1 receptor expressed in COS7 cells (2) or in CHO and BHK cells (3) , it has been shown that activation of the D1 receptor in brain tissue (4, 5) or in Xenopus oocytes injected with mRNA taken from striatum (6) resulted in PI turnover. This discrepancy suggests the involvement of a factor in D1 receptormediated PLC activity that is present in native tissues but absent in heterologous expression
systems. An examination of the above studies where PLC activation was observed indicates that, although D1 receptor-selective antagonists blocked PI turnover demonstrating the involvement of the D1 receptor, the amount of agonist used to elicit the response was greater than 100 µM, a concentration at which even selective ligands may bind other receptors. For example, SKF 81297, a highly D1-selective agonist, has a Ki for the D1 receptor of ~1 nM, but has a Ki for the D2 receptor of ~900 nM (7) . This analysis suggests the possibility that the D1 agonist-mediated PLC stimulation by high concentrations of drugs observed in physiological systems may have resulted from the coincident activation of another receptor.
There is considerable data indicating that the dopamine D1 and D2 receptors are functionally linked. For example, behavioral studies have shown that co-stimulation of the D1 receptor is essential for D2 agonists to produce maximal locomotor stimulation (8) and that 4 gene expression (10, 11) . Also, long-term depression of synaptic transmission after dopamine depletion could be restored by dopamine or co-administration of specific D1 and D2 agonists but not by either selective agonist alone (12) . Although the mechanism for the D1-D2 receptor interaction in these studies showing functional linkage is not clearly understood, there is evidence that an interaction between the receptors occurring within the same cell may be involved in some instances. For example, synergistic potentiation of the D2 receptor-mediated enhancement of arachidonic acid release by co-administration of D1-selective and D2-selective agonists in cells expressing both receptors has been observed (13) . Furthermore, it has been
shown that D1 subclass and D2 subclass receptors are co-expressed in neurons of the rat striatum (14) suggesting the possibility that there may be a direct D1-D2 receptor association.
Therefore, we postulated that dopaminergic PLC-mediated calcium signaling results from the co-activation of dopamine D1 and D2 receptors and the formation of a novel signaling unit represents the molecular basis for the functional interaction between these receptors. In investigating this hypothesis, we demonstrated that co-activation of co-expressed D1 and D2
receptors resulted in a PLC-mediated increase of intracellular calcium levels, a signaling pathway not activated when either one of the receptors was singly activated. Further, we also found evidence that D1 and D2 receptors associate within neurons and thereby potentially form a novel signaling complex.
Experimental Procedures
Cell culture and receptor expression -All cell culture and transfection reagents were obtained from Invitrogen (Carlsbad, CA). COS7 and HEK293T cells were maintained as monolayer cultures at 37ºC in minimal essential medium supplemented with 10% fetal bovine serum and antibiotics. Transient expression was performed using Lipofectamine™ with DNA encoding human D1 receptor or the long isoform of the human dopamine D2 receptor that had been inserted into pcDNA3 vector (Invitrogen). For immunoprecipitation experiments, HA and FLAG epitope tags were introduced after the initiation methionine of the D1 and D2 receptors respectively by PCR. Stable cell lines co-expressing the N-terminus HA-epitope tagged D1
receptor and N-terminus FLAG-epitope tagged human D2 receptor were created in HEK293TSA cells utilizing the pBudCE 4.1 vector (Invitrogen). Briefly, the D1 receptor cDNA was inserted into the EF1α multicloning site and the D2 receptor cDNA into the CMV site. Antibioticresistant clones (selected with 200 µg/mL zeocin) of each transfection were isolated and tested for expression of corresponding receptors using saturation binding analysis. Generation of striatal cultures -Neuronal cultures derived from the rodent striatum were generated using standard protocols. Briefly, striatal tissue was dissected from newborn rats (P1) and washed with calcium-and magnesium-free HEPES-buffered saline (HBSS and 9E10 anti-c-myc (Santa Cruz Biotechnology, Santa Cruz, CA) antibodies were used for detection of the HA and c-myc epitopes respectively. For immunoprecipitation from brain, striatal tissue was dissected from adult female Sprague-Dawley rats and the procedure was carried out using a protocol described previously (18) . Striatal membranes (500 µg) were solubilized and incubated with 5 µg rabbit anti-rat D1 (Chemicon #AB1765P) or rabbit anti-rat D2 (Chemicon #AB5084P). Eluted protein was resolved by electrophoresis and then transferred onto PVDF membranes for Western blot analysis. Immunoblots were probed using a monoclonal D1 receptor antibody (Sigma-Aldrich #D-187). shown to endogenously express G protein-coupled P2Y1 and P2Y2 purinergic receptors that stimulate PLC via Gq coupling when activated (19) . Interestingly, the rate of calcium signal propagation is distinct for these two receptors as the P2Y2 receptor-mediated signal occurs at a faster rate than the signal mediated by P2Y1 receptors (20) . The agonist-induced increase in intracellular calcium-dependent fluorescence by the D1 and D2 receptor co-activation was temporally similar to that detected for Gq-coupled P2Y1 purinergic receptors activated by ATP ( Figure 1E ).
Measurement of calcium signal -

Results
Co-activation of D1 and D2 receptors elevates intracellular calcium
To confirm the requirement for concurrent activation of both D1 and D2 receptors in order to evoke calcium signal in cells expressing both D1 and D2 receptors, cells co-expressing D1 and D2 receptors were treated with either SCH 23390, a D1-selective antagonist, alone, or with eticlopride, a D2-selective antagonist, alone. Notably, the dual agonist-induced calcium signal was attenuated by the addition of SCH 23390 or by the addition of eticlopride ( Figure 1F ).
We hypothesized that dopamine treatment would elicit calcium influx in a manner similar to that arising by concurrent administration of SKF 81297 and quinpirole. No change in intracellular calcium levels was generated by dopamine in cells expressing only D1 or D2 dopamine receptors, however, when cells co-expressing D1 and D2 receptors were incubated with dopamine, an increase in intracellular calcium levels was seen (Figure 2A) . Again, the agonist-induced intracellular calcium increase could be blocked by the addition of SCH 23390 or eticlopride ( Figure 2B ).
In order to examine whether coupling to the adenylyl cyclase signaling pathway was affected by co-expression of D1 and D2 receptors, we examined cells co-expressing D1 and D2 receptors stimulated with SKF81297 or with quinpirole ( Figure 3 ). The ability of the D1 receptor to stimulate adenylyl cyclase and of the D2 receptor to inhibit adenylyl cyclase was unaffected.
There was no statistically significant difference in the maximum stimulation of adenylyl cylcase and the EC50 between the D1-D2 receptor expressing cells and cells expressing only the D1 receptor. The same was true for the maximum inhibition of adenylyl cylcase and the EC50 between the D1-D2 receptor expressing cells and cells expressing only the D2 receptor. These observations suggest that cells expressing both receptors may be capable of evoking three distinct dopamine-mediated signals simultaneously.
Signal transduction pathway for D1-D2 receptor co-activation -In order to determine the mechanism of the calcium signal generation, we attempted to block key components of several signal transduction pathways while co-stimulating the receptors with both D1-and D2-selective agonists.
Gs protein activation by the D1 receptor has been implicated in calcium signaling via protein kinase A (PKA) -mediated mechanisms (21) (22) (23) . Therefore, cells expressing D1 and D2
receptors were treated with H89, an inhibitor of PKA, and co-activated by D1 and D2 receptor agonists. There was no effect of H89 on the increase in intracellular calcium levels, suggesting that co-activated D1 and D2 receptor-mediated calcium signaling was not dependent on PKA ( Figure 4A ).
We then examined whether simultaneously activated D1 and D2 receptors increase intracellular calcium levels via a PLC-dependent pathway. Cells were treated with U73122, a PLC inhibitor. Notably, the increase in intracellular calcium levels by D1 and D2 receptor coactivation was markedly attenuated (>90%) after treatment with U73122 ( Figure 4A ). U73122 also inhibited the calcium signal mediated by the endogenous, Gq-linked P2Y receptors ( Figure   4B ), indicating that the inhibitor was blocking PLC. These results suggest that, when coactivated, D1 and D2 receptors may couple to Gq and signal through an IP pathway to cause the release of intracellular calcium.
G protein-coupled receptor stimulation of PLC may also occur via a protein kinase C (PKC) -mediated mechanism (24) . Furthermore, there is evidence that lipid products of phosphoinositide 3-kinase (PI3K) action may generate a PLC-mediated calcium signal (25) . We therefore investigated whether PKC or PI3K played a role in generating the calcium signal evoked by co-activated D1 and D2 receptors. When cells co-expressing D1 and D2 receptors were treated with bisindolamide I, a PKC inhibitor, and co-stimulated with D1 and D2 agonists, no attenuation of calcium signal was observed ( Figure 4A ), suggesting that PLC was not stimulated by the actions of PKC. Similarly, when we examined the effects of the PI3K inhibitor, wortmannin, on the D1-D2 receptor mediated calcium signal, no significant changes were detected, suggesting no role for PI3K in the novel signal generated by D1-D2 receptor coactivation ( Figure 4A ). receptor-mediated calcium signal in HEK 293 cells was also partially blocked (~25-30%) by PTX ( Figure 4C ). These observations suggest that PTX may diminish the Gq-mediated calcium signal by co-activated D1-D2 receptors in a non-specific manner, but that the Gi pathway is not directly involved in the generation of the signal. D1 and D2 receptors are colocalized in neurons -In order to determine if there was a physiological basis for the novel response by D1 and D2 receptor co-activation, we examined whether these two receptors were co-expressed and co-localized within the same neurons. The expression of D1 and D2 receptors within neurons in brain tissues and cultured neurons was analyzed. D1-like and D2-like receptors have been shown to be co-localized in neurons of the rodent striatum (14) , however, there has been some controversy as to whether the D1 and D2
Pharmacological characterization of co-expressed D1 and D2 receptors -
receptor subtypes are co-expressed in the same cell (14, 28) . Using antibodies that were specific for the D1 and D2 receptors, we substantiated the subtype selectivity and performed immunohistochemical analysis of human and rat brain. In the caudate nucleus, prominent immunolabel was observed for both D1 and D2 receptors in cell bodies of individual medium spiny neurons ( Figure 5A ). Distinct puncta corresponding to immunolabel for both receptors could be observed which overlapped significantly in cells expressing both D1 and D2 receptors.
In the rat frontal cortex ( Figure 5B ), pyramidal cells were shown to co-express both D1
and D2 receptors while interneurons appearing to only express D2 receptors were observed.
Within cortical pyramidal neurons, immunolabel for both receptors was co-localized in neurites up to at least 40 µm away from the cell body. Neuronal processes were also observed originating from the same neuron that contained either exclusively D1 receptor immunolabel or D2 receptor immunolabel ( Figure 5B, arrows) , suggesting the possibility of at least three distinct populations of dopamine receptors within the same cell.
In neuronal cultures derived from neonatal rat striatum, D1 and D2 receptor were coexpressed in a significant proportion of cells ( Figure 5C ). D2 receptor immunostaining was observed in every neuron examined, with intense immunolabel both in the cell bodies and throughout the full extent of their dendrites. Expression of D1 receptors was distinct from that of D2 receptors in that staining was observed in only 40-60% of neurons, and, in most cases, immunolabeling was restricted to the cell body and proximal dendrites. receptors were co-expressed in COS7 cells and immunoprecipitated using anti-HA and anti-cmyc antibodies ( Figure 7A ). When HA-antibody precipitates were imunoblotted with a c-myc probe, a band corresponding to the D2 receptor was immunodetected. Similarly, coimmunoprecipitation of HA-D1 receptor with c-myc antibody was also observed.
In blots of immunoprecipitates from rat striatal membranes ( Figure 7B ), a ~50 kD band corresponding to the D1 receptor was detected in proteins purified with a D1 receptor antibody ( Figure 7B , lane 1). When immunoprecipitation for the D2 receptor was performed and the precipitate was probed for the D1 receptor, the D1 receptor was detected ( Figure 7B , lane 2),
indicating that D1 and D2 receptor were part of the same protein complex in rat striatum.
Discussion
In this study, we have provided the first demonstration that two co-expressed G proteincoupled receptors, when co-activated, can form a completely novel signaling complex. We have shown that concurrent agonist activation of co-expressed dopamine D1 and D2 receptors evoked a PLC-mediated elevation of intracellular calcium levels, a cellular response not generally associated with these receptors which have been shown to predominantly signal via the adenylyl cyclase effector system. The activation of a Gq-linked pathway by a complex of D1 and D2
receptors is an exciting prospect, given that these receptors are thought to transduce signal predominantly by coupling to Gs/olf and Gi/o proteins, respectively. The calcium signal was not Our analyses showed that neurons and regions within neurons were populated by D1 or D2 receptors exclusively, and by co-localized, interacting D1 and D2 receptors, and cells that express both receptors were able to mediate both stimulation and inhibition of adenylyl cyclase in addition to generating a calcium signal. Therefore, it is likely that there are at least three different types of dopaminergic signaling units generated by these two receptor subtypes. The nature of a signaling pathway activated by D1 receptors may completely depend on whether or not the D1 receptors are associated with D2 receptors.
The precise mechanism by which Gq couples to the D1-D2 heteromeric complex remains to be determined. The direct interaction of Gq with the D1 receptor upon co-activation with the D2 receptor, or Gq coupling to D2 receptor mediated by co-activation with the D1 receptor are both possibilities. Interestingly, there is recent evidence that only one G protein is associated for each receptor homodimer of the BLT1 leukotriene B4 receptor (33) . A similar configuration was recently speculated to be the case for rhodopsin, based on crystallography data which indicates that, given the relative sizes of G proteins and rhodopsin, only one G protein could associate with a receptor homodimer due to spatial restrictions (34) . These studies suggest a third possibility in which G protein selectivity may be determined by the conformation of both the D1 and D2
receptors.
Indirect calcium signaling by the D1 receptor has been shown to occur in some heterologous expression systems (21) (22) (23) . This response is attributed to cAMP and PKA since identical calcium increases can be induced by cAMP analogs and can be blocked by PKA inhibitors. In our study, PKA inhibitor treatment did not attenuate the intracellular calcium increases observed, thus excluding this pathway as a potential mechanism of calcium activation by co-activated D1 and D2 receptors. Crosstalk between Gi-and Gq-coupled receptors mediated by Gβγ exchange has been observed to result in potentiation of Gq-mediated signaling due to Gicoupled receptor activation (35) . A crosstalk mechanism does not appear to underlie the novel signaling unit generated by co-activated D1 and D2 receptors since our observations indicate that neither receptor couples to a Gq pathway in the absence of concurrent activation of both receptors. It has also been demonstrated that a single transmembrane domain protein known as calcyon can interact with the D1 receptor to allow D1 receptor-mediated increases in intracellular calcium levels (36) . However, the activation of the calcyon-D1 receptor complex requires "priming" by the prior activation of a co-expressed Gq-coupled receptor and, therefore, calcyon is unlikely to be involved in the calcium signal seen in this study.
It was important to establish a physiological basis for D1 and D2 receptor interaction as there has been considerable controversy concerning whether or not D1 and D2 receptors are colocalized within the same neurons (14,28). Aizman and co-workers have reported that, in the rat striatum, virtually all neurons expressing D1 subclass receptors also express D2 subclass receptors (14) . However, in situ hybridization studies have shown that D1 and D2 receptors do not have completely overlapping distributions in the striatum (37) (38) (39) . Using highly specific D1
and D2 receptor antibodies and confocal laser microscopy of human caudate, rat striatum, and cultured neurons from rat striatum, we have shown that these two receptors were co-expressed and co-localized within a significant number of neurons.
In conclusion, we have established using classical inhibitors of various signal transduction mechanisms that co-activated D1 and D2 receptors can signal via a PLC-mediated calcium pathway, a pathway not activated by either receptor alone. We have also shown D1 and D2 receptors are co-expressed and co-localized within neurons and that these two receptors are part of the same protein complex. Numerous earlier studies have suggested that these receptors were functionally linked. Therefore, making a logical progression from previous studies of the (40)). In future studies, it would be intriguing to investigate whether this calcium signaling by co-activated D1 and D2 receptors is related to schizophrenia and other dopamine-related disorders. 
